To include LCNEC, we expanded our antibody panel not only with vimentin, which can serve as a marker for sarcomatoid carcinoma [8], but also with neurendocrine markers (CD56, Synaptophysin, Chromogranin A). This evidence concerns the gene NCAM1 and sarcomatoid carcinoma.